Description

Health Canada is pleased to announce the implementation of International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance E9(R1): Defining the Appropriate Estimand for a Clinical Trial/ Sensitivity Analyses.

Resources

Name	Format	Description	Link
Notice – Release of ICH E9(R1): Defining the Appropriate Estimand for a Clinical Trial/ Sensitivity Analyses	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/efficacy/notice-ich-e9-r1-defining-appropriate-estimand-clinical-trial-sensitivity-analysis.html
Notice – Release of ICH E9(R1): Defining the Appropriate Estimand for a Clinical Trial/ Sensitivity Analyses	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/international-conference-harmonisation/efficacite/avis-ich-e9-r1-estimes-analyse-sensibilite-essais-cliniques.html

Tags

Topics

Categories